October 5, 2020

Milbank Recognized as ‘Intellectual Property Firm to Watch’ by LMG Life Sciences

Share

Milbank LLP was recognized as ‘Intellectual Property Firm to Watch’ by LMG Life Sciences at the virtual ceremony for the 2020 Americas Awards on September 23, 2020. Errol Taylor was also shortlisted as ‘Hatch-Waxman Litigator of the Year’ in the ninth edition of LMG Life Sciences. Presented by the research arm of Euromoney’s Legal Media Group, this guide serves as a comprehensive breakdown of life sciences industry leaders on both the firm and attorney level that specialize in corporate, regulatory, litigation and intellectual property matters.

Milbank’s Intellectual Property practice (IP) provides comprehensive and sophisticated IP services that achieve extraordinary results for our clients’ most challenging matters. Our Litigation practice, which offers a comprehensive approach to dispute resolution and problem-solving, favors neither plaintiffs nor defendants: our attorneys have obtained – and defeated – nine-figure damage claims for our clients. In addition to litigation, Milbank provides pre-litigation counselling, infringement and validity opinions, transactional IP expertise (including negotiation of complex licensing arrangements), representation in post-grant patent office proceedings prosecution, and assistance with alternative dispute resolution and settlement negotiations. Milbank’s IP lawyers have extensive experience in the life sciences sector, managing the intersection of pharma patent litigation and FDA and FTC issues, and negotiating numerous complex settlements in Hatch-Waxman and BPCIA litigation.

Errol Taylor represents research pharmaceutical, biotechnology and chemical companies in patent litigation, appeals and related counseling. He has over 25 years of experience advising companies in complex patent issues and transactions. Mr. Taylor and has long been recognized as one of the world’s leading pharmaceutical lawyers.

To view the full list of awards, please click here.